1. Proton Pump Inhibitor–Refractory Gastroesophageal Reflux Disease
   Rena Yadlapati et al, 2019, Medical Clinics of North America CrossRef
2. Efficacy of vonoprazan for initial and maintenance therapy in reflux esophagitis, nonerosive esophagitis, and proton pump inhibitor-resistant gastroesophageal reflux disease
   Yasuhiko Gotoh et al, 2020, Medicine CrossRef
3. Diagnosis and Treatment of Refractory GERD
   Alexandra Selby et al, 2023, Current Treatment Options in Gastroenterology CrossRef
4. Vonoprazan versus proton-pump inhibitors for gastric endoscopic submucosal dissection-induced ulcers: a systematic review and meta-analysis
   Veeravich Jaruvongvanich et al, 2018, European Journal of Gastroenterology & Hepatology CrossRef
5. Real-World Evidence to Evaluate the Efficacy and Safety of Vonoprazan in Gastrointestinal Disorders in the Pakistani Population
   Amanullah Abbasi et al, 2023, Cureus CrossRef
6. Role of Acid Suppression in Acid-related Diseases: Proton Pump Inhibitor and Potassium-competitive Acid Blocker
   Hideki Mori et al, 2019, Journal of Neurogastroenterology and Motility CrossRef
7. Recomendaciones de buena práctica clínica en el diagnóstico y tratamiento de la enfermedad por reflujo gastroesofágico. Revisión por expertos de la Asociación Mexicana de Gastroenterología
   M.A. Valdovinos-Diaz et al, 2024, Revista de Gastroenterología de México CrossRef
8. Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2021
   Katsuhiko Iwakiri et al, 2022, Journal of Gastroenterology CrossRef
9. Incidence and type of adverse events in patients taking vonoprazan: A systematic review and meta-analysis
   Wentao Xu et al, 2023, Therapeutic Advances in Gastroenterology CrossRef
10. Long-term outcomes of patients with symptomatic gastroesophageal reflux disease treated with vonoprazan
    Satoshi Shinozaki et al, 2018, Scandinavian Journal of Gastroenterology CrossRef
11. Taking the ‘sauer’ out of sauerkraut: a rapid update on the pathophysiology and treatment of gastro-oesophageal reflux disease
    L Brand et al, 2020, South African General Practitioner CrossRef
12. Efficacy of Seven-Day Potassium-Competitive Acid Blocker-Based First-LineHelicobacter PyloriEradication Therapy Administered with Bismuth
    Ji Yeon Kim et al, 2021, Yonsei Medical Journal CrossRef
13. Refractory Gastroesophageal Reflux Disease: A Management Update
    Francesco Rettura et al, 2021, Frontiers in Medicine CrossRef
14. BRAZILIAN CLINICAL GUIDELINE FOR THE THERAPEUTIC MANAGEMENT OF GASTROESOPHAGEAL REFLUX DISEASE (BRAZILIAN FEDERATION OF GASTROENTEROLOGY, FBG)
    Joaquim Prado P MORAES-FILHO et al, 2024, Arquivos de Gastroenterologia CrossRef
15. Trends in gastroesophageal reflux disease research: A bibliometric and visualized study
    Tai Zhang et al, 2022, Frontiers in Medicine CrossRef
16. Taking the 'sauer' out of sauerkraut : a rapid update on the pathophysiology and treatment of gastro-oesophageal reflux disease
    L. Brand Brand et al, 2020, South African General Practitioner CrossRef
17. Management of gastroesophageal reflux disease
    Russell Roark et al, 2020, Disease-a-Month CrossRef
18. Randomised clinical trial: comparison of tegoprazan and placebo in non‐erosive reflux disease
    Seung Han Kim et al, 2021, Alimentary Pharmacology & Therapeutics CrossRef
19. Gastroesophageal Reflux Disease
    Rena Yadlapati et al, 2019, Gastrointestinal and Liver Disorders in Women’s Health CrossRef
20. Good clinical practice recommendations for the diagnosis and treatment of gastroesophageal reflux disease. An expert review from the Asociación Mexicana de Gastroenterología
    M.A. Valdovinos Díaz et al, 2024, Revista de Gastroenterología de México (English Edition) CrossRef